Skip to content

Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia.

Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia. - Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009140
Enrollment
300
Registered
2012-12-15
Start date
2012-12-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypereosinophilic syndrome, chronic eosinophilic leukemia, idiopathic eosinophilia.

Interventions

None listed

Sponsors

Kobe University Medical School Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinically diagnosed or suspected cases of Myeloproliferative disorders with eosinophilia. Healthy volunteer.

Exclusion criteria

Exclusion criteria: Definite diagnosed secondary eosinophilia.

Design outcomes

Primary

MeasureTime frame
Exploration of disease specific biomarkers in Myeloproliferative disorders with eosinophilia.

Countries

Japan

Contacts

Public ContactAkiko Sada

Department of Medicine, Kobe University Graduate School of Medicine Division of Hematology

akikosad@med.kobe-u.ac.jp078-382-5111(6912)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026